Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,840,363
-$410,753 QoQ
Shares Held
72,990
+1.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#265
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $425,890,657 across 14 Drug Manufacturers - General names. AZN ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
412,665 | $104,804,529 | |
| 2 | LLY |
ELI LILLY & Co
|
78,019 | $93,578,336 | |
| 3 | MRK |
Merck & Co., Inc.
|
563,132 | $72,362,462 | |
| 4 | ABBV |
AbbVie Inc.
|
209,332 | $52,676,303 | |
| 5 | AMGN |
Amgen Inc
|
87,050 | $31,522,545 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
439,307 | $25,312,868 | |
| 7 | PFE |
Pfizer Inc
|
879,706 | $21,183,319 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
72,990 | $13,840,363 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,840,363 | 72,990 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $14,251,116 | 72,260 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||